Omnicell Inc (OMCL)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: ELECTRONIC COMPUTERS

590 E. MIDDLEFIELD ROAD MOUNTAIN VIEW, CA 94043

Provides patient safety solutions. The company's range of solutions is designed for many clinical areas of the healthcare facility: the central pharmacy, nursing units, operating room, cardiac catheterization lab and the patient's bedside.

Data as of 2020-09-12
Market Cap3.073 Billion Shares Outstanding42.763 Million Avg 30-day Volume345.415 Thousand
P/E Ratio64.4 Dividend Yield EPS1.13
Price/Sales3.39 Price cash flow ratio19.3 Price free cash flow ratio30.8
Book Value20.75 Price to Tangible Book9.09 Alpha0.01
Short Interest Ratio % Short Interest to Float R-squared0.182771
BETA0.920288 52-week High/Low94.85 / 54.24 Stddev0.091977
View SEC Filings from OMCL instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 4 -100.0% 0 (0.0%) 3 (0.19%) -100.0%
Funds Holding: 287 300 -4.33% 62 (4.04%) 74 (4.73%) -16.22%
13F shares: 42.505 Million 40.855 Million 4.04% 14.94 Million 13.622 Million 9.68%
% Ownership 99.3966 95.9002 3.65% 34.9363 31.9749 9.26%
New Positions: 33 43 -23.26% 10 13 -23.08%
Increased Positions 110 111 -0.9% 22 21 4.76%
Closed Positions 43 35 22.86% 22 12 83.33%
Reduced Positions 115 108 6.48% 29 37 -21.62%
Total Calls 38.801 Thousand 32.345 Thousand 19.96% 38.8 Thousand 4.9 Thousand 691.84%
Total Puts 11.5 Thousand 2.9 Thousand 296.55% 11.5 Thousand
PUT/CALL Ratio 0.3 0.09 233.33% 0.3 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding OMCL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding OMCL BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

22.6 Thousand total shares from 5 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LIPPS RANDALL A CHAIRMAN, PRESIDENT AND CEO

  • Officer
  • Director
656,658 2020-09-15 16

SPEARS JOSEPH BRIAN CHIEF ACCOUNTING OFFICER & VP

  • Officer
15,993 2020-09-15 6

SEIDELMANN SCOTT PETER EVP, CHIEF COMMERCIAL OFFICER

  • Officer
64,645 2020-06-16 9

NGO NHAT H EVP, MARKETING, S & B D

  • Officer
59,847 2020-06-15 4

JOHNSTON DAN S EVP & CHIEF LEGAL & ADMIN

  • Officer
59,124 2020-06-15 5

KUIPERS PETER J. EXECUTIVE V P& CFO

  • Officer
112,929 2020-06-15 4

SEIM ROBIN GENE DIRECTOR

  • Director
71,405 2020-05-26 1

WHITE SARA J

  • Director
76,960 2020-05-26 1

JUDSON JAMES T

  • Director
40,838 2020-05-26 1

MOORE VANCE B.

  • Director
77,539 2020-05-26 1

PARRISH MARK W

  • Director
63,829 2020-05-26 1

BAUER JOANNE B

  • Director
34,620 2020-05-26 2

SMITH BRUCE D.

  • Director
42,993 2020-05-26 1

SCOTT BRUCE E

  • Director
6,547 2020-05-26 1

PETERSMEYER GARY S

  • Director
16,013 2019-05-14 0

TABORGA JORGE R. EVP, GLOBAL R & D

  • Officer
71,180 2019-03-11 0

DREW J CHRISTOPHER PRESIDENT, NORTH AMERICAN A&A

  • Officer
No longer subject to file 2018-06-05 0

LINDHOLM RANDY D

  • Director
No longer subject to file 2016-10-07 0

ORTIGAS-WEDEKIND MARGA VICE PRESIDENT, MARKETING

  • Officer
60,823 2015-03-31 0

STEVENSON MICHAEL D EXEC. VP, GLOBAL MANUFACTURING

  • Officer
22,523 2013-12-16 0

WEGMILLER DONALD C

  • Director
26,397 2013-08-12 0

WHITTERS JOSEPH E

  • Director
96,002 2012-11-08 0

FOLEY MARY E

  • Director
36,720 2012-08-14 0

SHIELDS WILLIAM G. EXECUTIVE VICE PRESIDENT

  • Officer
25,000 2012-06-05 0

YOUNGER WILLIAM H JR

  • Director
37,520 2012-02-15 0

CHOMA JOHN VP, PROFESSIONAL SVCS & CLO

  • Officer
15,316 2009-07-01 0

LUHR RENEE M VP SALES

  • Officer
48,750 2008-08-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

LIPPS RANDALL A - Director - Officer CHAIRMAN, PRESIDENT AND CEO in trust with wife

2020-09-16 19:56:32 -0400 2020-09-16 S 300 $76.15 d 240,548 indirect 0.3644 0.3644 2 0.0 1

LIPPS RANDALL A - Director - Officer CHAIRMAN, PRESIDENT AND CEO in trust with wife

2020-09-16 19:56:32 -0400 2020-09-16 S 13,443 $75.63 d 240,848 indirect 0.3644 0.3644 2 0.0 1

LIPPS RANDALL A - Director - Officer CHAIRMAN, PRESIDENT AND CEO in trust with wife

2020-09-16 19:56:32 -0400 2020-09-15 S 1,400 $75.01 d 254,291 indirect 0.3644 0.3644 2 0.0 1

SPEARS JOSEPH BRIAN - Officer CHIEF ACCOUNTING OFFICER & VP

2020-09-15 18:58:21 -0400 2020-09-15 F 190 d 15,993 direct 1.0255 -7.757 1.3936 3 -7.757 6

SPEARS JOSEPH BRIAN - Officer CHIEF ACCOUNTING OFFICER & VP

2020-08-10 17:31:25 -0400 2020-08-06 A 6,301 a 6,301 direct

SPEARS JOSEPH BRIAN - Officer CHIEF ACCOUNTING OFFICER & VP

2020-08-10 17:31:25 -0400 2020-08-06 A 2,204 d 16,183 direct 2.3059 -2.5781 0.487 10.4555 28 -4.4973 15

LIPPS RANDALL A - Director - Officer CHAIRMAN, PRESIDENT AND CEO

2020-07-30 12:42:33 -0400 2020-07-29 S 3,718 $75.15 d 148,398 direct -1.458 -4.6124 0.743 2.0749 30 -6.519 23

LIPPS RANDALL A - Director - Officer CHAIRMAN, PRESIDENT AND CEO in trust with wife

2020-09-02 19:34:50 -0400 2020-07-29 S 3,718 $75.15 d 255,691 indirect -0.456 2.3938 3.7475 5 -1.0259 3

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments